Temporal Lobe Epilepsy and Psychiatric Symptoms

Temporal lobe epilepsy carries the highest burden of psychiatric symptoms among all epilepsy types, with roughly half of people who have drug-resistant forms also meeting criteria for at least one psychiatric disorder. Depression and anxiety are the most common, but the list extends to psychosis, personality changes, and a distinctive mood state that doesn’t fit neatly into standard psychiatric categories. What makes temporal lobe epilepsy unusual is not just the frequency of these problems but the way the seizure focus itself, nestled among brain structures that regulate emotion and memory, seems to drive them biologically rather than merely coexist with them.

How Common Are Psychiatric Problems in Temporal Lobe Epilepsy

The numbers vary depending on who is studied and how strictly diagnoses are applied, but the overall picture is consistent: people with temporal lobe epilepsy (TLE) develop psychiatric conditions far more often than those with seizures originating elsewhere in the brain. One study of drug-resistant focal epilepsy found that patients with a temporal focus had a significantly higher overall rate of psychiatric comorbidities than those with extratemporal epilepsy, driven largely by more anxiety disorders in the temporal group.¹ In a comparison of 170 patients with refractory TLE and mesial temporal sclerosis against 100 patients with juvenile myoclonic epilepsy, half of each group had a psychiatric diagnosis. The breakdown, though, was telling: mood disorders led in the temporal group at about 26%, followed by psychosis at nearly 16% and anxiety at 14%. Psychosis was significantly more common in the temporal group, while anxiety was actually higher in the generalized epilepsy group.²

Broader estimates suggest that while about a fifth to a third of all people with epilepsy have a psychiatric disorder, the figure in TLE specifically climbs to somewhere between 40% and 80%, depending on the population studied and whether seizures respond to medication.³ The people at greatest risk tend to be those with hippocampal sclerosis and those whose seizures resist medication. These two factors compound one another: structural damage to a brain region critical for emotion and memory, combined with ongoing seizure activity, creates a biological environment that favors psychiatric complications.

Depression and the Temporal Lobe

Depression is the single most studied psychiatric complication of TLE. It is not simply the expected sadness of living with a chronic illness. Research consistently shows that the relationship between TLE and depression involves shared neurobiology, not just shared suffering. Disrupted serotonin and noradrenaline signaling, combined with abnormal interactions between these systems and the brain’s excitatory glutamate circuits, has been identified in both epilepsy and depression.⁴ The overlap runs deep enough that researchers have described a bidirectional relationship: depression increases the risk of developing epilepsy, and epilepsy increases the risk of depression, suggesting that neither simply causes the other but that both emerge from similar underlying brain changes.

Neuroimaging reinforces this idea. In people with right-sided TLE, those who also had depression showed significantly smaller left hippocampal volumes than those without depression.⁵ More broadly, when chronic untreated depression co-occurs with mesial temporal lobe epilepsy, the areas of brain atrophy visible on imaging expand considerably beyond what seizures alone would produce.⁶ Depression doesn’t just pile onto the effects of epilepsy; it appears to amplify the structural damage in overlapping brain regions.

Inflammation adds another layer. People with TLE and depression have higher blood levels of interleukin-1 beta, an inflammatory signaling molecule, compared to both healthy people and TLE patients without depression. The higher those levels, the more severe the depressive symptoms tend to be.⁷ Broader research on the link between epilepsy and depression has identified a web of inflammatory processes, including activation of immune cells in the brain, release of pro-inflammatory cytokines, and oxidative damage, all of which contribute to disrupted signaling between nerve cells.⁸ In people with mesial TLE and psychiatric comorbidities, neuroinflammatory patterns even differ depending on whether the person has depression versus psychosis, with psychosis-associated tissue showing higher levels of immune cell activation in specific hippocampal subregions.⁹

Anxiety and Its Outsized Impact on Daily Life

Anxiety in TLE often gets overshadowed by the focus on depression and psychosis, which is unfortunate because anxiety may be the single biggest driver of poor quality of life. Two independent studies of quality of life in temporal lobe epilepsy reached the same conclusion: anxiety symptoms were the most powerful negative predictor of how patients rated their overall well-being, outweighing seizure frequency, medication side effects, and depression.¹⁰¹¹

The biology of anxiety in TLE traces heavily to the amygdala, a small almond-shaped structure at the core of the temporal lobe that acts as the brain’s alarm system. In mesial TLE, the amygdala sits right in the zone of seizure activity, and its connections to the rest of the brain become abnormal. Functional imaging work has revealed that these connectivity disturbances differ depending on which side the seizure focus is on: right-sided TLE appears to have a more disruptive impact on the brain’s emotion-processing networks than left-sided TLE, in ways that are specific to which part of the amygdala is involved and which emotional symptom you measure.¹² Experimental and imaging data also suggest that the amygdala’s role differs between seizure-related fear and between-seizure anxiety. Changes in serotonin receptors and other neurochemical systems within the amygdala have been linked to emotional disturbances in TLE, and the structural findings diverge: ictal fear is associated with amygdala volume loss, whereas interictal depression often appears alongside an intact or enlarged amygdala.¹³

Recent work examining specific hippocampal subregions found that anxiety symptoms in drug-resistant mesial TLE were linked to smaller volume in the posterior dentate gyrus, even after accounting for other variables, while depression did not show the same structural correlations with hippocampal subfield size.¹⁴ The message from this research is that anxiety and depression in TLE, though they frequently coexist, appear to have at least partially distinct structural substrates.

Psychosis in Temporal Lobe Epilepsy

Psychosis is less common than depression or anxiety in TLE but more diagnostically challenging. Interictal psychosis, the form that occurs between seizures in clear consciousness, typically develops years into the course of the disease. Risk factors identified through systematic review include early age of epilepsy onset, a history of prolonged seizure episodes (status epilepticus), hippocampal sclerosis, and abnormalities predominantly in the left hemisphere.¹⁵ Family history of psychosis, learning disability, poorly controlled seizures, and a history of febrile seizures in childhood also raise the risk.¹⁶

Structural brain changes in TLE patients who develop psychosis set them apart from those who don’t. People with TLE and interictal psychosis tend to show cortical thinning in the inferior frontal gyrus, a region also implicated in schizophrenia, along with worse cognitive performance and greater lifetime exposure to status epilepticus. The pattern suggests that psychosis in TLE reflects an interaction between genetic vulnerability to psychotic illness and the accumulated impact of seizure activity on the brain’s structure.¹⁷

Forced Normalization and the Seizure-Psychosis Seesaw

One of the most counterintuitive phenomena in epilepsy psychiatry is forced normalization: the emergence of psychotic symptoms precisely when seizures come under control and epileptic discharges on EEG disappear. First described by Landolt in 1953, the concept suggests that in some patients the brain maintains a kind of balance between seizure activity and psychosis, and that suppressing one can unleash the other.¹⁸ In practical terms, this means a patient whose seizures finally stop after a medication change or surgical intervention may, paradoxically, develop psychotic symptoms for the first time.¹⁹

Case reports illustrate how this plays out at the bedside. Two TLE patients developed prolonged psychotic episodes lasting around 12 weeks after a burst of seizures followed by a lucid interval. During the psychotic period, their usual EEG abnormalities vanished. Standard antipsychotic medications helped little. The psychotic symptoms gradually resolved only once their epileptic discharges returned on the EEG.²⁰ Forced normalization remains relatively rare and poorly understood, but it matters clinically because it can mislead treatment teams into thinking a new psychiatric illness has appeared when what they are really seeing is a consequence of seizure control itself.

When Seizures Mimic Panic Attacks

Temporal lobe seizures can produce intense, sudden fear as their primary symptom, a phenomenon called ictal fear. This can look strikingly similar to a panic attack, and misdiagnosis in both directions happens regularly. Patients with TLE sometimes spend years being treated for panic disorder, while some people with genuine panic disorder undergo unnecessary epilepsy evaluations.

The distinguishing features are subtle but consistent. Ictal fear typically lasts under two minutes, often includes a rising sensation in the stomach, may involve déjà vu or brief lapses in awareness, and frequently leads to post-event confusion or amnesia. Panic attacks, by contrast, build over several minutes, peak within about ten minutes, occur in full alertness, are more variable in their presentation from episode to episode, and commonly lead to anticipatory anxiety and agoraphobia between attacks.²¹²² Automatisms, small repetitive movements like lip-smacking or hand-fumbling during the episode, are a strong pointer toward epilepsy. And the response to treatment differs: panic disorder usually improves with antidepressants or cognitive behavioral therapy, while ictal fear requires antiseizure medication.

How Anti-Seizure Medications Can Make Things Worse

Treatment of TLE itself can contribute to psychiatric problems, creating a frustrating catch-22. Levetiracetam, one of the most widely prescribed anti-seizure medications, has the highest rate of psychiatric and behavioral side effects among commonly used drugs. One study found that about 22% of adults taking levetiracetam developed psychiatric or behavioral problems, a rate nearly seven times higher than the aggregate of other anti-seizure medications. Intolerability led to dose reductions in roughly one in ten patients and complete discontinuation in a similar proportion.²³ Reported side effects range from irritability and agitation to depression and psychosis, with psychosis estimated to develop in about 1.4% of patients on the drug.²⁴

On the other side of the medicine cabinet, several older anti-seizure drugs, including carbamazepine, lamotrigine, and valproate, were associated with lower rates of psychiatric side effects, and some of these (lamotrigine and valproate in particular) have established mood-stabilizing properties of their own.²⁵ When antidepressants are added for comorbid depression, the choice matters too. Newer antidepressants like SSRIs and SNRIs appear to be safe and may even improve seizure control, while older tricyclic antidepressants can lower the seizure threshold and increase seizure frequency.²⁶ For anyone with TLE and depression, these interactions make a conversation with a neurologist essential before starting or changing any psychiatric medication.

What Surgery Can and Cannot Do for Psychiatric Symptoms

Temporal lobe surgery, usually removal of the seizure-generating region, is the most effective treatment for drug-resistant TLE and is sometimes expected to improve psychiatric symptoms along with seizures. The reality is mixed. A meta-analysis of surgical outcomes found that about 43% of patients showed improvement in psychiatric symptoms after surgery, but roughly a third actually got worse.²⁷

More recent evidence suggests that depression and anxiety tend to decrease by about a year after surgery, reversing earlier concerns from older studies that had found increases in these conditions post-operatively. However, new-onset psychosis can emerge after surgery in patients who never had it before, at rates estimated between 1% and 14%. Risk factors for this de novo psychosis include bilateral temporal damage, the presence of tumors rather than the more typical mesial temporal sclerosis, and recurrence of seizures after an initial seizure-free period.²⁸ The takeaway is that surgery can genuinely help with mood and anxiety, but psychiatric monitoring should continue long after the surgical wound has healed.

Cognitive Behavioral Therapy as an Alternative

Given the complexities of drug interactions and the incomplete results from surgery, non-drug treatments for psychiatric symptoms in TLE deserve more attention than they typically get. A pilot study compared cognitive behavioral therapy (CBT) directly against SSRIs in TLE patients with major depression. After 12 weeks, both groups showed improvements in depression severity and quality of life, with no significant difference between the two approaches. The effect on quality of life was actually somewhat larger for the CBT group.²⁹ An earlier pilot study had found that CBT produced significant improvements in depression starting around week eight of treatment, along with better quality of life scores.³⁰

These are small studies and not definitive proof, but they suggest that CBT is a viable option, particularly for people who are wary of adding yet another medication to an already complicated regimen or who have experienced psychiatric side effects from their anti-seizure drugs. CBT also has no known interaction with seizure threshold, which gives it a safety advantage over some pharmacological options.

Suicide Risk and the Importance of Screening

The psychiatric burden of TLE carries real consequences for safety. In one study of 66 TLE patients, about 29% were identified as having some degree of suicide risk, and 21% had made at least one attempt. The factors most closely associated with this risk were seizure frequency, current major depression, and impulsivity, specifically the motor component of impulsivity rather than the cognitive planning aspects.³¹ These findings underscore why psychiatric screening in TLE should not be treated as optional. A person whose seizures are poorly controlled and who screens positive for depression warrants close follow-up, and asking directly about suicidal thoughts remains the most reliable way to identify those at highest risk.

Geschwind Syndrome and Personality Changes

Beyond the standard psychiatric diagnoses, TLE has long been linked to a distinctive cluster of personality and behavioral features known as Geschwind syndrome. The classic description includes excessive writing (hypergraphia), heightened religiosity, circumstantial and overly detailed speech, and reduced sexual interest. These traits are not a formal psychiatric diagnosis and are not present in most people with TLE, but they have been described often enough in the clinical literature to become part of the cultural understanding of temporal lobe epilepsy. More recent clinical observation suggests that these behavioral features are not unique to TLE and can appear in other neurological and psychiatric conditions, which has led some researchers to question whether they should be considered specific to temporal lobe epilepsy at all.³²

Psychiatric Symptoms in Children with Temporal Lobe Epilepsy

The psychiatric complications of TLE are not an adult-only problem. Children and adolescents with TLE show higher rates of depression, anxiety, and behavioral problems than healthy peers and even than children with other chronic illnesses like diabetes or asthma. This pattern mirrors what is seen in adults, but the stakes in younger patients are compounded by the impact on learning, social development, and identity formation during critical developmental windows.³³ Cognitive and behavioral impairments frequently travel alongside the psychiatric symptoms, creating a cluster of difficulties that can be difficult for families and school systems to disentangle from the epilepsy itself. Early recognition and treatment of psychiatric comorbidities in pediatric TLE can prevent years of compounding academic and social difficulty, but it requires clinicians to look beyond seizure control as the sole marker of treatment success.